These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 8474460

  • 1. Positive and negative modulation of Jun action by thyroid hormone receptor at a unique AP1 site.
    Lopez G, Schaufele F, Webb P, Holloway JM, Baxter JD, Kushner PJ.
    Mol Cell Biol; 1993 May; 13(5):3042-9. PubMed ID: 8474460
    [Abstract] [Full Text] [Related]

  • 2. Transcriptional silencing by unliganded thyroid hormone receptor beta requires a soluble corepressor that interacts with the ligand-binding domain of the receptor.
    Tong GX, Jeyakumar M, Tanen MR, Bagchi MK.
    Mol Cell Biol; 1996 May; 16(5):1909-20. PubMed ID: 8628257
    [Abstract] [Full Text] [Related]

  • 3. The orphan receptor Rev-ErbA alpha activates transcription via a novel response element.
    Harding HP, Lazar MA.
    Mol Cell Biol; 1993 May; 13(5):3113-21. PubMed ID: 8474464
    [Abstract] [Full Text] [Related]

  • 4. Novel pathway for thyroid hormone receptor action through interaction with jun and fos oncogene activities.
    Zhang XK, Wills KN, Husmann M, Hermann T, Pfahl M.
    Mol Cell Biol; 1991 Dec; 11(12):6016-25. PubMed ID: 1944274
    [Abstract] [Full Text] [Related]

  • 5. Positive regulation of the skeletal alpha-actin gene by Fos and Jun in cardiac myocytes.
    Bishopric NH, Jayasena V, Webster KA.
    J Biol Chem; 1992 Dec 15; 267(35):25535-40. PubMed ID: 1460048
    [Abstract] [Full Text] [Related]

  • 6. Epstein-Barr virus BZLF1 transactivator is a negative regulator of Jun.
    Sato H, Takeshita H, Furukawa M, Seiki M.
    J Virol; 1992 Aug 15; 66(8):4732-6. PubMed ID: 1321269
    [Abstract] [Full Text] [Related]

  • 7. Fos is a preferential target of glucocorticoid receptor inhibition of AP-1 activity in vitro.
    Kerppola TK, Luk D, Curran T.
    Mol Cell Biol; 1993 Jun 15; 13(6):3782-91. PubMed ID: 8497279
    [Abstract] [Full Text] [Related]

  • 8. Opposing actions of Fos and Jun on transcription of the phosphoenolpyruvate carboxykinase (GTP) gene. Dominant negative regulation by Fos.
    Gurney AL, Park EA, Giralt M, Liu J, Hanson RW.
    J Biol Chem; 1992 Sep 05; 267(25):18133-9. PubMed ID: 1325459
    [Abstract] [Full Text] [Related]

  • 9. The proto-oncogenes c-fos and c-jun modulate thyroid hormone inhibition of human thyrotropin beta subunit gene expression in opposite directions.
    Bodenner DL, McClaskey JH, Kim MK, Mixson AJ, Weintraub BD.
    Biochem Biophys Res Commun; 1992 Dec 15; 189(2):1050-6. PubMed ID: 1335239
    [Abstract] [Full Text] [Related]

  • 10. Induction of the DNA-binding activity of c-jun/c-fos heterodimers by the hepatitis B virus transactivator pX.
    Natoli G, Avantaggiati ML, Chirillo P, Costanzo A, Artini M, Balsano C, Levrero M.
    Mol Cell Biol; 1994 Feb 15; 14(2):989-98. PubMed ID: 7507209
    [Abstract] [Full Text] [Related]

  • 11. Jun and Fos heterodimerize with ATFa, a member of the ATF/CREB family and modulate its transcriptional activity.
    Chatton B, Bocco JL, Goetz J, Gaire M, Lutz Y, Kedinger C.
    Oncogene; 1994 Feb 15; 9(2):375-85. PubMed ID: 8290251
    [Abstract] [Full Text] [Related]

  • 12. Analysis of the hormone-dependent regulation of a JunD-estrogen receptor chimera.
    Francis MK, Phinney DG, Ryder K.
    J Biol Chem; 1995 May 12; 270(19):11502-13. PubMed ID: 7744790
    [Abstract] [Full Text] [Related]

  • 13. Cooperative transcriptional activity of Jun and Stat3 beta, a short form of Stat3.
    Schaefer TS, Sanders LK, Nathans D.
    Proc Natl Acad Sci U S A; 1995 Sep 26; 92(20):9097-101. PubMed ID: 7568080
    [Abstract] [Full Text] [Related]

  • 14. A novel mechanism of thyroid hormone-dependent negative regulation by thyroid hormone receptor, nuclear receptor corepressor (NCoR), and GAGA-binding factor on the rat cD44 promoter.
    Kim SW, Ho SC, Hong SJ, Kim KM, So EC, Christoffolete M, Harney JW.
    J Biol Chem; 2005 Apr 15; 280(15):14545-55. PubMed ID: 15701601
    [Abstract] [Full Text] [Related]

  • 15. Dominant and nondominant negative C-erbA beta 1 receptors associated with thyroid hormone resistance syndromes augment 12-O-tetradecanoyl-phorbol-13-acetate induction of the collagenase promoter and exhibit defective 3,5,3'-triiodothyronine-mediated repression.
    Ways DK, Qin W, Cook P, Parker PJ, Menke JB, Hao E, Smith AM, Jones C, Hershman JM, Geffner ME.
    Mol Endocrinol; 1993 Sep 15; 7(9):1112-20. PubMed ID: 8247013
    [Abstract] [Full Text] [Related]

  • 16. Regulation of human glutathione S-transferase pi gene transcription: influence of 5'-flanking sequences and trans-activating factors which recognize AP-1-binding sites.
    Morrow CS, Goldsmith ME, Cowan KH.
    Gene; 1990 Apr 16; 88(2):215-25. PubMed ID: 2112105
    [Abstract] [Full Text] [Related]

  • 17. Regulation of human NAD(P)H:quinone oxidoreductase gene. Role of AP1 binding site contained within human antioxidant response element.
    Li Y, Jaiswal AK.
    J Biol Chem; 1992 Jul 25; 267(21):15097-104. PubMed ID: 1340765
    [Abstract] [Full Text] [Related]

  • 18. Regulation of endothelin-1 gene expression by Fos and Jun.
    Lee ME, Dhadly MS, Temizer DH, Clifford JA, Yoshizumi M, Quertermous T.
    J Biol Chem; 1991 Oct 05; 266(28):19034-9. PubMed ID: 1918021
    [Abstract] [Full Text] [Related]

  • 19. Insulin-like growth factor-I stimulates c-fos and c-jun transcription in PC12 cells.
    Monnier D, Boutillier AL, Giraud P, Chiu R, Aunis D, Feltz P, Zwiller J, Loeffler JP.
    Mol Cell Endocrinol; 1994 Sep 05; 104(2):139-45. PubMed ID: 7988742
    [Abstract] [Full Text] [Related]

  • 20. Adenovirus early region 3 promoter regulation by E1A/E1B is independent of alterations in DNA binding and gene activation of CREB/ATF and AP1.
    Kornuc M, Kliewer S, Garcia J, Harrich D, Li C, Gaynor R.
    J Virol; 1990 May 05; 64(5):2004-13. PubMed ID: 2139139
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.